International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Irini Sereti, MD
National Institute of Allergy and Infectious Diseases (NIAID)
Study Director - Renee Ridzon, MD
National Institute of Allergy and Infectious Diseases (NIAID)
Study Director - Sally Hunsberger, PhD
National Institute of Allergy and Infectious Diseases (NIAID)
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- National Institute for Biomedical Research/institut National de Recherche Biomédicale (inrb)
Gombe, Kinshasa City, Democratic Republic of the Congo
- Partnership for Clinical Research in Guinea/partenariat de Recherche Clinique En Guinée (pregui)
Conakry, Guinea
- National Institute of Health Research and Development (nihrd), Ministry of Health, Republic of Jakarta - Rsu Kabupaten Tangerang
Tangerang, Indonesia
- Partnership for Research in Vaccines and Infectious Diseases in Liberia (prevail) - Duport Road Health Center
Monrovia, Liberia
- University Clinical Research Center (ucrc) University of Sciences, Techniques and Technologies of Bamako
Bamako, Mali
- Hospital Regional de Alta Especialidad "ciudad Salud" Hrae-Cs
Tapachula, Chiapas, Mexico
- Hospital General Dr. Manuel Gea Gonzalez (hgmgg)
Mexico City, Mexico
- Instituto Nacional de Ciencias Medicas Y Nutricion Salvador Zubiran (incmnsz),
Mexico City, Mexico
- Instituto Nacional de Enfermedades Respiratorias (iner)
Mexico City, Mexico
- Hospital General Dr. Aurelio Valdivieso (hgav)
Oaxaca City, Mexico
- Onom Foundation and Liver Center
Ulaanbaatar, Mongolia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Aug 2021
- Primary completion
- 19 Aug 2025
- Completion
- 19 Aug 2025
- Last update posted
- 18 Dec 2025
- Registered enrollment
- 5,399
- Registry id
- NCT05096091
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.